Semi-Annual Statement Of Cash Flows

KYORIN Pharmaceutical Co., Ltd. - Filing #7373032

Concept As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
9,880,000,000 JPY
3,881,000,000 JPY
Interest and dividends received
268,000,000 JPY
247,000,000 JPY
Interest paid
-33,000,000 JPY
-34,000,000 JPY
Income taxes paid
-1,751,000,000 JPY
-1,319,000,000 JPY
Net cash provided by (used in) operating activities
8,364,000,000 JPY
6,218,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-937,000,000 JPY
-2,314,000,000 JPY
Proceeds from sale of property, plant and equipment
0 JPY
9,000,000 JPY
Purchase of investment securities
0 JPY
-100,000,000 JPY
Other, net
-475,000,000 JPY
-372,000,000 JPY
Net cash provided by (used in) investing activities
327,000,000 JPY
-3,707,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-100,000,000 JPY
-100,000,000 JPY
Dividends paid
-1,853,000,000 JPY
-1,855,000,000 JPY
Net cash provided by (used in) financing activities
-2,020,000,000 JPY
-2,030,000,000 JPY
Other, net
-66,000,000 JPY
-74,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
95,000,000 JPY
231,000,000 JPY
Net increase (decrease) in cash and cash equivalents
6,767,000,000 JPY
711,000,000 JPY
Cash and cash equivalents
25,584,000,000 JPY
18,816,000,000 JPY
27,001,000,000 JPY
26,289,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.